Acute pancreatitis is a serious disease in which 20-30% of patients may develop severe pancreatitis with up to 40% mortality. As treatment is more likely to succeed if initiated early, rapid diagnosis of acute pancreatitis is vital.

Effective and Easy

• Convenient
• Simple, immediate sample analysis
• Novel acute pancreatitis screening method

Actim™ Pancreatitis is an immunochromatography dipstick test based on monoclonal antibodies detecting trypsinogen-2 from urine. Trypsinogen-2 is a more reliable marker for acute pancreatitis than amylase as its levels stay elevated for days or even weeks, while amylase levels start to decline after 1-3 days. This specific and sensitive test can rule out acute pancreatitis with at least 99% certainty, thus allowing patients with other conditions to be correctly diagnosed sooner. The accurate screening is easy to perform and enables patients really at risk to undergo further testing procedures as early as possible.